11/25/2014 - 12:04pm

Recently, NACDS provided a summary of the 2014 midterm elections, with an emphasis on the federal level. This memo includes an overview of the state elections, which will shape the operating environment on pivotal state issues.

11/24/2014 - 10:25am

Perrigo on Monday announced that it has agreed to market the authorized generic version of Astellas U.S.' Protopic ointment 0.1% and 0.03%. 

11/24/2014 - 9:52am

Dr. Reddy's Labs on Monday announced the launch of docetaxel injection USP in 20-mg and 80-mg dosage strengths. The drug is the generic version of Taxotere.

 

11/21/2014 - 12:16pm

A study being published in Annals of Internal Medicine suggests that people with atrial fibrillation who take NSAIDs may be at risk for serious bleeding or thromboembolisms. 

11/20/2014 - 3:48pm

Purdue Pharma on Thursday announced that the Food and Drug Administration approved Hysingla ER (hydrocodone bitartrate) extended‐release tablets CII, a once‐daily, single‐entity medication formulated using Purdue’s proprietary extended‐release solid oral platform, Resistec.

11/20/2014 - 1:06pm

Amneal Pharmaceuticals on Thursday announced the launch of Lopreeza (estradiol/norethindrone acetate) tablets in 0.5-mg and 1-mg dosage strengths. The product is the first authorized generic of Activella from Novo Nordisk.

 

11/20/2014 - 10:42am

Dr. Reddy’s Labs announced Thursday that it has launched a bioequivalent generic version of Allegra-D 12 Hour Allergy and Congestion, in the U.S. market.

11/20/2014 - 10:26am

Rite Aid on Thursday announced Quality Independent Physicians, based in Louisville, Ky., as the latest healthcare provider to join its Rite Aid Health Alliance initiative. 

 

11/20/2014 - 10:18am

The Consumer Healthcare Products Association board of directors on Wednesday announced changes to CHPA’s voluntary guidelines addressing dosing of liquid pediatric over-the-counter medicines.